DAFNA Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,100
| Closed | -$222K | – | 91 |
|
|
2022
Q2 | $222K | Hold |
3,100
| – | – | 0.06% | 85 |
|
|
2022
Q1 | $304K | Sell |
3,100
-2,500
| -45% | -$245K | 0.08% | 87 |
|
|
2021
Q4 | $475K | Hold |
5,600
| – | – | 0.12% | 83 |
|
|
2021
Q3 | $447K | Hold |
5,600
| – | – | 0.12% | 77 |
|
|
2021
Q2 | $545K | Hold |
5,600
| – | – | 0.11% | 81 |
|
|
2021
Q1 | $655K | Sell |
5,600
-1,000
| -15% | -$117K | 0.16% | 79 |
|
|
2020
Q4 | $734K | Hold |
6,600
| – | – | 0.22% | 63 |
|
|
2020
Q3 | $784K | Hold |
6,600
| – | – | 0.25% | 61 |
|
|
2020
Q2 | $747K | Sell |
6,600
-7,000
| -51% | -$792K | 0.22% | 67 |
|
|
2020
Q1 | $908K | Hold |
13,600
| – | – | 0.38% | 54 |
|
|
2019
Q4 | $1.24M | Buy |
13,600
+7,000
| +106% | +$638K | 0.43% | 54 |
|
|
2019
Q3 | $569K | Hold |
6,600
| – | – | 0.21% | 67 |
|
|
2019
Q2 | $692K | Hold |
6,600
| – | – | 0.26% | 64 |
|
|
2019
Q1 | $827K | Hold |
6,600
| – | – | 0.36% | 58 |
|
|
2018
Q4 | $744K | Buy |
+6,600
| New | +$744K | 0.37% | 54 |
|